PETS Petmed Express Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PETS

Price (delayed)

$1.81

Market cap

$38.67M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.74

Enterprise value

$17.8M

?
Relative Growth: Rel. Growth: 10
Relative Strength: Rel. Strength: 9
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 4

Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct ...

Highlights
PETS's debt is down by 46% year-on-year and by 18% since the previous quarter
Petmed Express's EPS has increased by 12% QoQ
The gross margin has contracted by 8% YoY but it has grown by 2.2% from the previous quarter
The equity has dropped by 66% year-on-year and by 12% since the previous quarter
The quick ratio has plunged by 51% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Pharmaceutical Retailers
Website: http://www.1800petmeds.com
Peers: CVS XNCR

Key stats

What are the main financial stats of PETS

PETS stock price

How has the Petmed Express stock price performed over time
Intraday
1.69%
1 week
-17.73%
1 month
-20.26%
1 year
-54.06%
YTD
-43.44%
QTD
-20.61%

Financial performance

How have Petmed Express's revenue and profit performed over time
Revenue
$179.02M
Gross profit
$50.22M
Operating income
-$58.67M
Net income
-$57.29M
Gross margin
28.1%
Net margin
-32%
PETS's gross profit is down by 27% year-on-year and by 2.4% since the previous quarter
The revenue has contracted by 21% YoY and by 4.2% from the previous quarter
The company's net income rose by 12% QoQ
PETS's net margin is up by 8% since the previous quarter

Price vs fundamentals

How does PETS's price correlate with its fundamentals

Growth

What is Petmed Express's growth rate over time

Valuation

What is Petmed Express stock price valuation
PETS P/E details
P/E
N/A
P/B
1.34
P/S
0.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.1
Petmed Express's EPS has increased by 12% QoQ
The equity has dropped by 66% year-on-year and by 12% since the previous quarter
The price to book (P/B) is 43% lower than the 5-year quarterly average of 2.3 and 18% lower than the last 4 quarters average of 1.6
The P/S is 79% below the 5-year quarterly average of 1.0 and 30% below the last 4 quarters average of 0.3
The revenue has contracted by 21% YoY and by 4.2% from the previous quarter

Efficiency

How efficient is Petmed Express business performance
PETS's ROE is down by 20% from the previous quarter
Petmed Express's return on sales has decreased by 3.5% QoQ
The company's return on assets fell by 4% QoQ

Dividends

What is PETS's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Petmed Express financials performed over time
Petmed Express's total assets is 55% more than its total liabilities
The quick ratio has plunged by 51% YoY and by 13% from the previous quarter
Petmed Express's total assets has decreased by 45% YoY and by 8% from the previous quarter
PETS's debt is 98% smaller than its equity
The company's debt to equity has surged by 100% YoY
The equity has dropped by 66% year-on-year and by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.